Poland - Pharmaceutical products

For more information and to make a bid you will need to go to the third party website.

Details

Provided by Open Opps
Opportunity closing date
06 October 2023
Opportunity publication date
08 September 2023
Category
33600000
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

The subject of the order is the supply of medicinal products, medicinal products purchased under targeted import and medical devices - 38 packages, on the terms and conditions specified in the draft provisions of the contract in quantities resulting from current needs and within the deadlines specified in the contract.
Lanreotidum, solution for injection, Octreotidum 10 mg, powder and solvent for prolonged-release solution for injection or powder and solvent for suspension for injection Octreotidum 30 mg, powder and solvent for prolonged-release solution for injection or powder and solvent for suspension for injection Medical products 1. Baclofenum 0.05 mg/ml x 5 ampoules of 1 ml each2. Baclofenum 0.5mg/ml x 1 ampoule of 20 ml each3. Baclofenum 2mg/ml x 1 ampoule of 5 ml each 1. Alteplasum 10 mg x 1 vial + solvent2. Alteplasum 20 mg x 1 vial + solvent Micafunginum 100 mg x 1 vial, powder for solution for infusion Micafunginum 50 mg x 1 vial, powder for solution for infusion Acidum gadotericum 0.5 mmol/ml x 1 vial of 10 ml, solution for injection. Without contraindications for use in children under 6 months of age. Amphotericinum B in liposomes, 50 mg x 1 vial +filter Foscarnet, sodium salt 24 mg/ml 1. Sirolimusum 0.1% (1 mg/ml), oral solution2. Sirolimusum 1 mg x 1. Human cytomegalovirus immunoglobulin, i.v., 100 U/ml with high titers of antibodies to CMV 2. Hepatitis B Immunoglobulin 50 IU/ml, solution for infusion Varicella Zoster Immunoglobulin 25 IU/ml Vinblastini sulfas 1 mg/ml x 1 vial 10 ml Phenobarbitalum 40 mg x 1 vial. Lomustinum 10 mg x 20 capsules Disopyramidum 100 mg Phytomenadione (vitamin K) 2mg/0.2ml x 5 ampoules - solution for injection and oral Colestyraminum 4 g Amphotericinum B 100 mg/ml, oral suspension 40 ml Methylene blue 2.5% Promethazinum 50mg/2 ml 1. Mexiletinum 100 mg 2. Mexiletinum 200 mg Pyrimethaminum 25 mg Tetracosactidum 0.25 mg/ml Thiaminum 50 mg/ml Corticoliberin 100 mcg x 1 ampoule + solvent Ethiodized oil, 480 mg/ml, shadowing agent, vial 10 ml Midazolamum 2.5 mg/0.5 ml; oral solution x 4 ampoule-syringeFood for special medical purposes, fat-free. Powder for preparation of oral solution. For the dietary management of infants from birth to 1 year of age and in older children as a dietary supplement. Food for special medical purposes, not containing protein. Powder for preparation of oral solution. For the dietary management of infants from birth to the completion of 1 year of age and in older children as a dietary supplement. Food for special medical purposes, not containing carbohydrates. Powder for preparation of oral solution,300 g package. For the dietary management of infants from birth and older children as a dietary supplement. 1.Sterile solution containing substances with anticoagulant and antimicrobial properties - (cyclo)taurolidine and citrate (4%). Used in port-type vascular accesses or vascular catheters to protect the lumen of catheters from clot formation and from bacterial and fungal infections x 10 amp. of 5ml2.Sterile solution containing substances with anticoagulant and antimicrobial properties - (cyclo)taurolidine and citrate (4%). Used in port-type vascular accesses or vascular catheters to protect the lumen of catheters from clot formation and from bacterial and fungal infections. 3.Sterile, apirogenic solution containing substances with anticoagulant and antimicrobial properties - (cyclo)taurolidine, citrate (4%) and heparin (Mucosa, 100lU/ml). Used in port-type vascular accesses or vascular catheters to protect the lumen of catheters from clot formation and from bacterial and fungal infections. 4.Sterile, apirogenic solution containing substances to prevent catheter clogging and with antimicrobial properties - (cyclo)taurolidine, citrate (4%) and urokinase (25,000 lU). Used in port-type vascular accesses or silicone or polyurethane catheters to protect flow chambers from clot formation and from bacterial and fungal infections. Electrolyte solution containing calcium and phosphate ions with moisturizing and cleansing effect on the oral mucosa, tongue and throat. 64 containers รก 15 ml. Free of benzalkonium chloride. Without contraindications for use in children. 3% Natrium hyaluronicum, viscoelastic fluid, ampoule-syringe 0.85 ml - 1 ml, storage temperature up to 30 degrees C.

Opportunity closing date
06 October 2023
Value of contract
to be confirmed

About the buyer

Address
Instytut "Pomnik-Centrum Zdrowia Dziecka" Al. Dzieci Polskich 20 Warszawa 04-730 Poland
Contact
zamowienia.publiczne@ipczd.pl

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?